Codice QR

Early costs and complications of first-line low-grade glioma treatment using a large national database: Limitations and future perspectives

IntroductionDiffuse Low-grade gliomas (DLGG, WHO Grade II) are a heterogenous group of tumors comprising 13–16% of glial tumors. While maximal safe resection is endorsed as the best approach to DLGG, compared to more conservative interventions like stereotactic biopsy, the added costs and risks have...

Descrizione completa

Salvato in:
Autori principali: Kyle Tuohy, Djibril M. Ba, Debarati Bhanja, Douglas Leslie, Guodong Liu, Alireza Mansouri
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2023-02-01
Serie:Frontiers in Surgery
Soggetti:
low-grade glioma (WHO grade II)
cost
resection
stereotactic biopsy
adverse events—complications
MarketScan database
Accesso online:https://www.frontiersin.org/articles/10.3389/fsurg.2023.1001741/full
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi